Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells

Current Eye Research

Volumn 37, Issue 5, 2012, Pages 421-428

  Sreenivasan, Seethalakshmi ^a   Thirumalai, Karthiyaini ^a   Danda, Ravikanth ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Curcumin; MicroRNA; Oncogene; Tumor suppressor gene; Y79 cells

Indexed keywords

CURCUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MICRORNA; MICRORNA 22; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SURVIVAL; CURCUMIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; TUMOR CELLS, CULTURED;

EID: 84859883099     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.647224     Document Type: Article

References (37)

1. Bagnyukova TV, Pogribny IP, Chekhun VF. MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Exp Oncol. 2006;28:263-269. (Pubitemid 46226095)
2. Doe JM. MicroRNA: Cancer and future treatment applications. Basic Biotech eJournal. 2008;36-42.
3. Liu Z, Sall A, Yang D. MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci. 2008;9:978-999. (Pubitemid 351948835)
4. Iorio MV, Ferracin M, Liu CG et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65:7065-7070. (Pubitemid 41161233)
5. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838. (Pubitemid 40839735)
6. Takamizawa J, Konishi H, Yanagisawa K et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753-3756. (Pubitemid 38697282)
7. Volinia S, Calin GA, Liu CG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257-2261. (Pubitemid 43271657)
8. Lee EJ, Gusev Y, Jiang J et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120:1046-1054. (Pubitemid 46214304)
9. He H, Jazdzewski K, Li W et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2005;102:19075-19080. (Pubitemid 43049568)
10. Vogel F. Genetics of retinoblastoma. Hum Genet 1979;52:1-54. (Pubitemid 10194798)
11. Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest Ophthalmol Vis Sci. 2009;50:4542-4551.
12. Zhao JJ, Yang J, Lin J et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009;25:13-20.
13. Li Y, VandenBoom TG 2nd, Kong D et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009;69:6704-6712.
14. Melkamu T, Zhang X, Tan J, Zeng Y, Kassie F. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis. 2010;31:252-258.
15. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther. 2008;7:464-473. (Pubitemid 351482129)
16. Tsang WP, Kwok TT. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem. 2010;21:140-146.
17. Tsang WP, Kwok TT. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res. 2010;27:1027-1041.
18. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-1421.
19. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41:1955-1968. (Pubitemid 41557681)
20. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20:7597-7609. (Pubitemid 33111860)
21. Sarkar FH, Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 2004;555:53-64. (Pubitemid 39345397)
22. Thiyagarajan S, Thirumalai K, Nirmala S, Biswas J, Krishnakumar S. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells. Curr Eye Rese. 2009;34:37-43.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408. (Pubitemid 34164012)
24. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60.
25. Hagen JW, Lai EC. microRNA control of cell-cell signaling during development and disease. Cell Cycle. 2008;7:2327-2332.
26. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363-398. (Pubitemid 36361976)
27. Xiong J, Yu D, Wei N et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J. 2010;277:1684-1694.
28. Pandey DP, Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol. 2009;29:3783-3790.
29. Zhang L, Volinia S, Bonome T et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA. 2008;105:7004-7009. (Pubitemid 351754520)
30. Jun Li, Shanhui Liang, Hailin Yu et al. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol. 2010;119:543-548.
31. Pandey DP, Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009;29:3783-3790.
32. Chang TC, Yu D, Lee YS et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43-50.
33. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787-798. (Pubitemid 38058492)
34. Chakraborty S, Khare S, Dorairaj SK, Prabhakaran VC, Prakash DR, Kumar A. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics. 2007;90:344-353. (Pubitemid 47176334)
35. Patel JB, Appaiah HN, Burnett RM et al. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene. 2011;30:1290-1301.
36. Yan C, Jamaluddin S Md, Aggarwal B et al. Gene expression profiling identifies activating transcriptionfactor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther. 2005;4:233-241. (Pubitemid 40340203)
37. Huang JC, Babak T, Corson TW et al. Using expression profiling data to identify human microRNA targets. Nat Methods. 2007;4:1045-1049. (Pubitemid 350201777)